Click here to read the PHARMAC DISPATCH dated 8 June 2018.

ProPharma have again been proactive and placed Letrole Tab 2.5 mg 30 on allocation of 3 per week per customer.

STAT dispensing was removed from 1 May 2018 until 1 August 2018 to assist in managing stock.

From 11 June 2018 an alternative brand Letromly Tab 2.5 mg 60 will be listed, fully funded for community use.

Due to being different pricing group we are not able in this instance to implement automatic replacement.

This is a TEMPORARY listing until 1 November 2018 and as such ProPharma / PWR will not accept any stock purchased back for credit.

Letromly is Medsafe registered.

Together we can make this a seamless and painless transition.

We thank you in anticipation of your ongoing support.

About The Author